<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-15743</title>
	</head>
	<body>
		<main>
			<p>941017 FT  17 OCT 94 / Company News This Week: SmithKline Beecham - Other Companies Third-quarter figures tomorrow will be scanned for clues to its progress in integrating DPS, the drug distributor bought for Dollars 2.3bn (Pounds 1.45bn) in May. It will also be the first full quarter to show the effects of the expiry of the patent on Tagamet, the ulcer drug. The nine-month pre-tax profit figure should nevertheless be well above Pounds 900m, against Pounds 841m.</p>
		</main>
</body></html>
            